News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Published Analysis Confirms Positive Results From Auris Medical AG's Phase 2b Study With AM-101 In Treatment Of Acute Inner Ear Tinnitus


3/31/2014 9:01:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BASEL, Switzerland, March 31, 2014 (GLOBE NEWSWIRE) -- Auris Medical announced today that results from its phase IIb clinical trial with AM-101 in the treatment of acute inner ear tinnitus have been published in the specialist journal Otology & Neurotology1. The trial demonstrated that AM-101 was well tolerated and safe and established proof of concept in the treatment of tinnitus arising from traumatic acoustic injury to the cochlea and otitis media. In particular the trial showed persistent, clinically relevant and statistically significant improvement in several patient-reported tinnitus measures.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES